Congratulations!
Duke University was one of 22 higher education institutions around the nation just selected to receive the SENCER (Science Education for New Civic Engagements and Responsibilities) award for implementing projects to improve science and math education in the U.S. The Duke recipients are in the RISE (Raising Interest in Science Education) office in the Department of Pharmacology & Cancer Biology. The RISE development team includes its director, Professor Rochelle Schwartz-Bloom ; a post-doctoral RISE Fellow, Nicole Kwiek ; an AB Duke undergraduate scholar, Joseph Babcock , and a high school student at Durham School of the Arts, Senmiao Zhan . Sherryl Broverman , an assistant professor of biology and a former SENCER awardee, completes the team. The team is developing a course in infectious disease and treatment called Superbugs, Science and Society for the high school curriculum. The Duke RISE team was the only team awaraded the grant for developing a course to focus on the high school population.

Congratulations!
Dr. Sally A. Kornbluth, Professor of Pharmacology and Cancer Biology, has been appointed as Vice Dean for Basis Science in the School of Medicine .

Means Appointed as Deputy Director of CCC
Tony Means, PhD, Nanaline H. Duke Professor and chairman of the Department of Pharmacology and Cancer Biology, has been appointed to the position of deputy director. Dr. Means is an internationally renowned basic research scientist and experienced administrator. In his role as deputy director, he will work with the Cancer Center’s senior leaders to develop new strategic initiatives to support the Cancer Center’s growing number of cancer investigators.

McDonnell as CCC's Associate Director of Basic Research
Donald McDonnell, PhD, Glaxo-Wellcome Professor of Molecular Cancer Biology, has assumed the role of associate director of basic research. Dr. McDonnell will help chart the future directions of the Cancer Center in basic research. He is internationally recognized for his contributions to the pharmacology of nuclear receptors.

Congratulations!
Dr. Daniel Lew has been elected Fellow of the American Academy of Microbiology, Class of 2008. The Academy, the honorific leadership group within the American Society for Microbiology, recognizes excellence, originality, and creativity in the microbiological sciences. Dr. Lew will be recognized at the Academy Fellows Luncheon and Meeting at the 108th ASM General Meeting in Boston, Massachusetts on Wednesday, June 4, 2008.

Top of page